2012 Annual Meeting | Inherited Neuropathies: From Bench to Bedside

Date Sunday 04/22/12

Time 02:00 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Steven Scherer, MD

Topic(s)

Learning Objectives Participants should learn the clinical phenotypes of CMT, cost-effective strategies to find the genetic causes of those phenotypes, and a view to what treatments might become available.

CME Available No CME available

Core Competencies Medical Knowledge, Practice-based Learning and Improvement

Program Tracks Subspecialty in Focus

Recommended Audience Specialist Neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Program Evaluations

Event Timeline
02:00 PM - 02:50 PM		Rational Approaches to Genetic Testing for Inherited Neuropathies Michael E. Shy, MD, FAAN
02:50 PM - 03:00 PM		Questions and Answers Michael E. Shy, MD, FAAN
03:00 PM - 03:50 PM		Medical Genetics at the Crossroads - Towards Large-scale Gene Screens Stephan Zuchner, MD, FAAN
03:50 PM - 04:00 PM		Questions and Answers
04:00 PM - 04:20 PM		Break
04:20 PM - 05:00 PM		Prospects for Treatments Steven Scherer, MD
05:00 PM - 05:10 PM		Questions and Answers Steven Scherer, MD
05:10 PM - 06:00 PM		Discussion

Faculty Disclosures
Michael E. Shy, MD, FAAN	Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.
Steven Scherer, MD	Dr. Scherer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Scherer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Scherer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Toray Industries. Dr. Scherer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. Dr. Scherer has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Disarm Therapeutics. Dr. Scherer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitochondria in Motion. The institution of Dr. Scherer has received research support from NIH .
Stephan Zuchner, MD, FAAN	Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.

��ɫ��

��ɫ��